Opposing Roles of JNK and p38 in Lymphangiogenesis in Melanoma

Journal of Investigative Dermatology

Volumn 136, Issue 5, 2016, Pages 967-977

  Puujalka, Emmi ^a   Heinz, Magdalena ^a   Hoesel, Bastian ^a   Friedl, Peter ^a   Schweighofer, Bernhard ^a   Wenzina, Judith ^a   Pirker, Christine ^b   Schmid, Johannes A ^a   Loewe, Robert ^a   Wagner, Erwin F ^c   Berger, Walter ^b   Petzelbauer, Peter ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c BBVA University Institute for Economic and Social Analysis University of Alcalá   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; INTERLEUKIN 6; INTERLEUKIN 8; JANUS KINASE 1; JANUS KINASE 2; MATRILYSIN; MESSENGER RNA; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MITOGEN ACTIVATED PROTEIN KINASE P38; OLIGONUCLEOTIDE; SHORT HAIRPIN RNA; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR SOX10; TRANSCRIPTION FACTOR SOX9; VASCULOTROPIN C; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE S PHASE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVITY; FOLLOW UP; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LYMPHANGIOGENESIS; MELANOMA; MELANOMA CELL LINE; METASTASIS; METASTATIC MELANOMA; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR XENOGRAFT; UPREGULATION; ANALYSIS OF VARIANCE; ANIMAL; DISEASE MODEL; DRUG SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HAIRLESS MOUSE; MALE; METABOLISM; MICROARRAY ANALYSIS; NONPARAMETRIC TEST; PATHOLOGY; PHYSIOLOGY; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN TUMOR; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; BIOMARKERS, TUMOR; BLOTTING, WESTERN; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LYMPHANGIOGENESIS; MALE; MELANOMA; MICE; MICE, HAIRLESS; MICROARRAY ANALYSIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; STATISTICS, NONPARAMETRIC; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR C; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84978129527     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1016/j.jid.2016.01.020     Document Type: Article

References (48)

1. Aikawa, Y., Morimoto, K., Yamamoto, T., Chaki, H., Hashiramoto, A., Narita, H., et al. Treatment of arthritis with a selective inhibitor of c-Fos/activator protein-1. Nat Biotechnol 26 (2008), 817–823.
2. Alitalo, A., Detmar, M., Interaction of tumor cells and lymphatic vessels in cancer progression. Oncogene 31 (2012), 4499–4508.
3. Balch, C.M., Gershenwald, J.E., Soong, S.J., Thompson, J.F., Atkins, M.B., Byrd, D.R., et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27 (2009), 6199–6206.
4. Bracher, A., Cardona, A.S., Tauber, S., Fink, A.M., Steiner, A., Pehamberger, H., et al. Epidermal growth factor facilitates melanoma lymph node metastasis by influencing tumor lymphangiogenesis. J Invest Dermatol 133 (2013), 230–238.
5. Carreira, S., Goodall, J., Denat, L., Rodriguez, M., Nuciforo, P., Hoek, K.S., et al. Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev 20 (2006), 3426–3439.
6. Cheli, Y., Giuliano, S., Fenouille, N., Allegra, M., Hofman, V., Hofman, P., et al. Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells. Oncogene 31 (2012), 2461–2470.
7. Chen, J.C., Chang, Y.W., Hong, C.C., Yu, Y.H., Su, J.L., The role of the VEGF-C/VEGFRs axis in tumor progression and therapy. Int J Mol Sci 14 (2013), 88–107.
8. Cianfarani, F., Mastroeni, S., Odorisio, T., Passarelli, F., Cattani, C., Mannooranparampil, T.J., et al. Expression of vascular endothelial growth factor-C in primary cutaneous melanoma predicts sentinel lymph node positivity. J Cutan Pathol 39 (2012), 826–834.
9. Dadras, S.S., Paul, T., Bertoncini, J., Brown, L.F., Muzikansky, A., Jackson, D.G., et al. Tumor lymphangiogenesis. Am J Pathol 162 (2003), 1951–1960.
10. Deng, X., Xiao, L., Lang, W., Gao, F., Ruvolo, P., May, W.S., Novel role for JNK as a stress-activated Bcl2 kinase. J Biol Chem 276 (2001), 23681–23688.
11. Doeden, K., Ma, Z., Narasimhan, B., Swetter, S.M., Detmar, M., Dadras, S.S., Lymphatic invasion in cutaneous melanoma is associated with sentinel lymph node metastasis. J Cutan Pathol 36 (2009), 772–780.
12. Du, Q., Jiang, L., Wang, X., Wang, M., She, F., Chen, Y., et al. Tumor necrosis factor-α promotes the lymphangiogenesis of gallbladder carcinoma of vascular endothelial growth factor-C. Cancer Sci 105 (2014), 1261–1271.
13. Guinea-Viniegra, J., Zenz, R., Scheuch, H., Jiménez, M., Bakiri, L., Petzelbauer, P., et al. Differentiation-induced skin cancer suppression by FOS, p53, and TACE/ADAM17. J Clin Invest 122:8 (2012), 2898–2910.
14. Hartman, M.L., Czyz, M., MITF in melanoma: mechanisms behind its expression and activity. Cell Mol Life Sci 72 (2015), 1249–1260.
15. Heinz, M., Niederleithner, H., Puujalka, E., Soler-Cardona, A., Grusch, M., Pehamberger, H., et al. Activin A is anti-lymphangiogenic in a melanoma mouse model. J Invest Dermatol 135 (2014), 212–221.
16. Hoek, K.S., Eichhoff, O.M., Schlegel, N.C., Döbbeling, U., Kobert, N., Schaerer, L., et al. In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res 68 (2008), 650–656.
17. Hoek, K.S., Goding, C.R., Cancer stem cells versus phenotype-switching in melanoma. Pigment Cell Melanoma Res 23 (2010), 746–759.
18. Hoek, K.S., Schlegel, N.C., Eichhoff, O.M., Widmer, D.S., Praetorius, C., Einarsson, S.O., et al. Novel MITF targets identified using a two-step DNA microarray strategy. Pigment Cell Melanoma Res 21 (2008), 665–676.
19. Howlin, J., Cirenajwis, H., Lettiero, B., Staaf, J., Lauss, M., Saal, L., et al. Loss of CITED1, an MITF regulator, drives a phenotype switch in vitro and can predict clinical outcome in primary melanoma tumours. PeerJ, 3, 2015, e788.
20. Jeltsch, M., Kaipainen, A., Joukov, V., Meng, X., Lakso, M., Rauvala, H., et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276 (1997), 1423–1425.
21. Karin, M., The regulaion of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270 (1995), 16483–16486.
22. Koludrovic, D., Davidson, I., MITF, the Janus transcription factor of melanoma. Futur Oncol 9 (2013), 235–244.
23. Lee, M.-H., Padmashali, R., Andreadis, S.T., JNK1 is required for lentivirus entry and gene transfer. J Virol 85 (2011), 2657–2665.
24. Loewe, R., Valero, T., Kremling, S., Pratscher, B., Kunstfeld, R., Pehamberger, H., et al. Dimethylfumarate impairs melanoma growth and metastasis. Cancer Res 66 (2006), 11888–11896.
25. Luangdilok, S., Box, C., Harrington, K., Rhŷs-Evans, P., Eccles, S., MAPK and PI3K signalling differentially regulate angiogenic and lymphangiogenic cytokine secretion in squamous cell carcinoma of the head and neck. Eur J Cancer 47 (2011), 520–529.
26. Mansky, K.C., Sankar, U., Han, J., Ostrowski, M.C., Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-κB ligand signaling. J Biol Chem 277 (2002), 11077–11083.
27. Mathieu, V., Pirker, C., Schmidt, W.M., Spiegl-Kreinecker, S., Lötsch, D., Heffeter, P., et al. Aggressiveness of human melanoma xenograft models is promoted by aneuploidy-driven gene expression deregulation. Oncotarget 3 (2012), 399–413.
28. Matsui, J., Funahashi, Y., Uenaka, T., Watanabe, T., Tsuruoka, A., Asada, M., Multi-kinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB-231 via inhibition of vascular endothelial growth factor-receptor (VEGF-R) 2 and VEGF-R3 kinase. Clin Cancer Res 14 (2008), 5459–5465.
29. McGill, G.G., Horstmann, M., Widlund, H.R., Du, J., Motyckova, G., Nishimura, E.K., et al. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 109 (2002), 707–718.
30. Mort, R.L., Jackson, I.J., Patton, E.E., The melanocyte lineage in development and disease. Development 142 (2015), 620–632.
31. Niederleithner, H., Heinz, M., Tauber, S., Bilban, M., Pehamberger, H., Sonderegger, S., et al. Wnt1 is anti-lymphangiogenic in a melanoma mouse model. J Invest Dermatol 132 (2012), 2235–2244.
32. Pastushenko, I., Vermeulen, P.B., Carapeto, F.J., Van Den Eynden, G., Rutten, A., Ara, M., et al. Blood microvessel density, lymphatic microvessel density and lymphatic invasion in predicting melanoma metastases: systematic review and meta-analysis. Br J Dermatol 170 (2014), 66–77.
33. Podgrabinska, S., Skobe, M., Role of lymphatic vasculature in regional and distant metastases. Microvasc Res 95 (2014), 46–52.
34. Roberts, N., Kloos, B., Cassella, M., Podgrabinska, S., Persaud, K., Wu, Y., et al. Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2. Cancer Res 66 (2006), 2650–2657.
35. Sahin, E., Haubenwallner, S., Kuttke, M., Kollmann, I., Halfmann, A., Dohnal, A.B., et al. Macrophage PTEN regulates expression and secretion of arginase I modulating innate and adaptive immune responses. J Immunol 193 (2014), 1717–1727.
36. Schietroma, C., Cianfarani, F., Lacal, P.M., Odorisio, T., Orecchia, A., Kanitakis, J., et al. Vascular endothelial growth factor-C expression correlates with lymph node localization of human melanoma metastases. Cancer 98 (2003), 789–797.
37. Schmid, J.A., Birbach, A., Hofer-Warbinek, R., Pengg, M., Burner, U., Furtmüller, P.G., et al. Dynamics of NF kappa B and Ikappa Balpha studied with green fluorescent protein (GFP) fusion proteins. Investigation of GFP-p65 binding to DNA by fluorescence resonance energy transfer. J Biol Chem 275 (2000), 17035–17042.
38. Shah, M., Bhoumik, A., Goel, V., Dewing, A., Breitwieser, W., Kluger, H., et al. A role for ATF2 in regulating MITF and melanoma development. PLoS Genet 6 (2010), 1–21.
39. Shakhova, O., Cheng, P., Mishra, P.J., Zingg, D., Schaefer, S.M., Debbache, J., et al. Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma. PLoS Genet, 11, 2015, e1004877.
40. Shields, J.D., Borsetti, M., Rigby, H., Harper, S.J., Mortimer, P.S., Levick, J.R., et al. Lymphatic density and metastatic spread in human malignant melanoma. Br J Cancer 90 (2004), 693–700.
41. Sosa, M.S., Parikh, F., Maia, A.G., Estrada, Y., Bosch, A., Bragado, P., et al. NR2F1 controls tumour cell dormancy via SOX9- and RARβ-driven quiescence programmes. Nat Commun, 30, 2014, 6170.
42. Stacker, S.A., Williams, S.P., Karnezis, T., Shayan, R., Fox, S.B., Achen, M.G., Lymphangiogenesis and lymphatic vessel remodelling in cancer. Nat Rev Cancer 14 (2014), 159–172.
43. Swoboda, A., Schanab, O., Tauber, S., Bilban, M., Berger, W., Petzelbauer, P., et al. MET expression in melanoma correlates with a lymphangiogenic phenotype. Hum Mol Genet 21 (2012), 3387–3396.
44. Tammela, T., Enholm, B., Alitalo, K., Paavonen, K., The biology of vascular endothelial growth factors. Cardiovasc Res 65 (2005), 550–563.
45. Tew, S.R., Hardingham, T.E., Regulation of SOX9 mRNA in human articular chondrocytes involving p38 MAPK activation and mRNA stabilization. J Biol Chem 281 (2006), 39471–39479.
46. Tsai, P.-W., Shiah, S.-G., Lin, M.-T., Wu, C.-W., Kuo, M.-L., Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway. J Biol Chem 278 (2003), 5750–5759.
47. Verfaillie, A., Imrichova, H., Atak, Z.K., Dewaele, M., Rambow, F., Hulselmans, G., et al. Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. Nat Commun, 6, 2015, 6683.
48. Wagner, E.F., Nebreda, A.R., Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9 (2009), 537–549.